The Point of Care Diagnostics Market is witnessing significant global growth, driven by the rising need for rapid, accurate, and decentralized diagnostic solutions across healthcare systems. According to industry estimates, the Point of Care Diagnostics Market size is projected to reach US$ 88.83 billion by 2031 from US$ 37.93 billion in 2024 , expanding at a strong CAGR of 13.0% during 2024–2031 . This growth is strongly influenced by key Point of Care Diagnostics Market Drivers , including the increasing prevalence of chronic and infectious diseases, growing demand for immediate diagnostic results, and the accelerating shift towards patient-centric and home-based healthcare services.

The market is evolving rapidly as healthcare providers increasingly adopt point of care testing (POCT) solutions to improve clinical efficiency and reduce diagnostic turnaround times. Technological advancements in biosensors, molecular diagnostics, and portable testing devices are enabling faster and more reliable disease detection, supporting improved patient outcomes across diverse care settings such as hospitals, clinics, pharmacies, and remote healthcare facilities.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00006394

Market Drivers of the Point of Care Diagnostics Market

A detailed analysis of the Market Drivers reveals that the growing global burden of infectious diseases and chronic conditions is one of the most significant factors fueling market expansion. Diseases such as diabetes, cardiovascular disorders, HIV, tuberculosis, and respiratory infections require timely diagnosis for effective treatment, and point of care diagnostics enables rapid testing and immediate clinical decision-making.

Another major driver is the increasing demand for decentralized and accessible healthcare services. Traditional laboratory diagnostics often involve delays due to sample transportation and processing time. In contrast, POCT allows testing to be conducted at or near the patient location, significantly improving healthcare efficiency. This is particularly beneficial in rural and underserved regions where access to centralized laboratories is limited.

Technological innovation is also a key growth driver. The integration of digital health technologies, artificial intelligence, and connected diagnostic devices has transformed the capabilities of POCT systems. Modern devices now offer real-time data sharing, remote monitoring, and improved diagnostic accuracy, making them highly valuable in both clinical and home care settings.

The rising adoption of home healthcare and self-testing solutions is further accelerating market growth. Aging populations, increasing healthcare expenditure, and patient preference for convenient care solutions are driving demand for at-home diagnostic kits, particularly for glucose monitoring, pregnancy testing, and infectious disease screening.

Additionally, the COVID-19 pandemic has significantly strengthened the adoption of point of care diagnostics worldwide. It highlighted the importance of rapid testing in managing public health emergencies and accelerated the deployment of antigen and molecular rapid testing solutions across global healthcare systems.

Market Trends and Competitive Landscape

The Point of Care Diagnostics Market is characterized by continuous innovation and expanding clinical applications. A key trend is the growing adoption of molecular point of care testing, which enables highly sensitive and specific detection of infectious agents within minutes. Another emerging trend is the integration of POCT devices with electronic health records (EHRs) and telemedicine platforms, improving data accessibility and clinical workflow efficiency.

Key companies operating in the market include:

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Siemens Healthineers
• Danaher Corporation
• Becton, Dickinson and Company (BD)
• QuidelOrtho Corporation
• bioMérieux SA
• Thermo Fisher Scientific Inc.
• Nova Biomedical
• Trinity Biotech Plc

These players are actively focusing on product innovation, strategic collaborations, and mergers and acquisitions to strengthen their global presence. Investments in portable, user-friendly, and highly accurate diagnostic systems remain a core strategy across leading companies.

Future Outlook

The future of the Point of Care Diagnostics Market remains highly promising, supported by continuous technological advancements and increasing healthcare decentralization. As healthcare systems globally prioritize early diagnosis, preventive care, and cost efficiency, POCT solutions are expected to play a central role in reshaping diagnostic workflows and improving patient care delivery through 2031.

About Us

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us

Ankit Mathur | The Insight Partners
Email: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish